Hims and Hers Health Inc vs Twist Bioscience Corp — how do they compare? Hims and Hers Health Inc trades at $30.62 (market cap $7.12B), while Twist Bioscience Corp trades at $124 (market cap $7.72B). The key difference: Hims and Hers Health Inc and Twist Bioscience Corp are close in size by market cap, and Twist Bioscience Corp is trading nearer its 52-week high, Hims and Hers Health Inc nearer its low. Which is the better fit depends on your goals.
| HIMS | TWST | |
|---|---|---|
Market Cap | $7.12B | $7.72B |
Sector | Health | Health |
52-Week High | $62.76 | $124.88 |
52-Week Low | $14.52 | $24.16 |
Enterprise Value | $7.82B | $7.65B |
Trailing returns across standard periods
Latest headlines on both assets
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →